Female Psoriatic Arthritis Patients Show Differences in Treatment Response to IL12/23 Inhibition in Combination with or Without MTX Compared to Male - Results from a Multicenter Investigator-initiated Randomized Placebo-controlled Clinical Trial

Koehm M, Foldenauer AC, Rossmanith T, Kellner H, Kiltz U, Rech J, Burmester G, Kofler D, Brandt-Juergens J, Finzel S, Bergner R, Sieburg M, Behrens F (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Arthritis and Rheumatology Wiley

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 3174-3176

Conference Proceedings Title: ARTHRITIS & RHEUMATOLOGY

Authors with CRIS profile

Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology

Involved external institutions

Goethe-Universität Frankfurt am Main

Germany (DE) Fraunhofer-Institut für Translationale Medizin und Pharmakologie (ITMP) / Fraunhofer Institute for Translational Medicine and Pharmacology

Germany (DE) Klinikum der Stadt Ludwigshafen am Rhein gGmbH

Germany (DE) Albert-Ludwigs-Universität Freiburg

Germany (DE) Charité - Universitätsmedizin Berlin

Germany (DE) Rheumazentrum Ruhrgebiet

Germany (DE) Universität zu Köln

Germany (DE)

How to cite

APA:

Koehm, M., Foldenauer, A.C., Rossmanith, T., Kellner, H., Kiltz, U., Rech, J.,... Behrens, F. (2022). Female Psoriatic Arthritis Patients Show Differences in Treatment Response to IL12/23 Inhibition in Combination with or Without MTX Compared to Male - Results from a Multicenter Investigator-initiated Randomized Placebo-controlled Clinical Trial. In ARTHRITIS & RHEUMATOLOGY (pp. 3174-3176). HOBOKEN: WILEY.

MLA:

Koehm, Michaela, et al. "Female Psoriatic Arthritis Patients Show Differences in Treatment Response to IL12/23 Inhibition in Combination with or Without MTX Compared to Male - Results from a Multicenter Investigator-initiated Randomized Placebo-controlled Clinical Trial." Proceedings of the ARTHRITIS & RHEUMATOLOGY HOBOKEN: WILEY, 2022. 3174-3176.

BibTeX: Download